$LFST
LifeStance Health Group, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023061118 Filed on November 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $280.6M $262.9M $217.6M
YoY Change 22.34% 20.84% 25.15%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $92.39M $130.9M $81.25M
YoY Change 3.53% 61.17% -50.14%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $22.22M $9.448M $7.680M
YoY Change 17.63% 23.02% 93.69%
% of Gross Profit
Operating Expenses $311.9M $337.3M $256.4M
YoY Change 13.5% 31.53% -14.11%
Operating Profit -$74.36M -$38.84M
YoY Change 91.45% -68.85%
Interest Expense -$5.532M $5.477M $4.189M
YoY Change 7.11% 30.75% 19.58%
% of Operating Profit
Other Income/Expense, Net -$513.0K -$3.611M -$3.367M
YoY Change -77.93% 7.25% -25.76%
Pretax Income -$38.32M -$77.97M -$42.21M
YoY Change -28.67% 84.73% -67.33%
Income Tax $6.643M -$16.39M -$4.353M
% Of Pretax Income
Net Earnings -$44.96M -$61.58M -$37.85M
YoY Change -3.64% 62.69% -68.57%
Net Earnings / Revenue -16.02% -23.42% -17.4%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.12 -$0.17 -$105.9K
COMMON SHARES
Basic Shares Outstanding 378.6M 378.0M 376.2M
Diluted Shares Outstanding 372.5K 357.5K

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $78.82M $42.60M $90.34M
YoY Change -27.43% -52.84% -57.41%
Cash & Equivalents $78.82M $42.61M $90.34M
Short-Term Investments
Other Short-Term Assets $10.73M $71.90M $48.97M
YoY Change -2.44% 46.83% 6.12%
Inventory
Prepaid Expenses
Receivables $125.4M $149.7M $113.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $225.7M $264.3M $252.6M
YoY Change -3.21% 4.62% -23.07%
LONG-TERM ASSETS
Property, Plant & Equipment $188.2M $190.1M $193.4M
YoY Change -3.07% -1.72% 68.1%
Goodwill $1.293B $1.293B $1.250B
YoY Change 1.6% 3.49% 7.74%
Intangibles $221.1M $233.6M $272.5M
YoY Change -16.04% -14.26% -11.53%
Long-Term Investments
YoY Change
Other Assets $10.90M $13.02M $11.42M
YoY Change 0.93% 14.08% 236.95%
Total Long-Term Assets $1.884B $1.911B $1.727B
YoY Change -2.91% 10.64% 8.87%
TOTAL ASSETS
Total Short-Term Assets $225.7M $264.3M $252.6M
Total Long-Term Assets $1.884B $1.911B $1.727B
Total Assets $2.110B $2.175B $1.980B
YoY Change -2.94% 9.87% 3.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.051M $10.40M $7.947M
YoY Change -42.6% 30.87% 158.52%
Accrued Expenses $35.01M $218.3M $90.88M
YoY Change 15.07% 140.21% 5.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.925M $2.595M $2.145M
YoY Change 24.73% 20.98% 62.13%
Total Short-Term Liabilities $202.9M $240.9M $112.3M
YoY Change 15.27% 114.55% 6.72%
LONG-TERM LIABILITIES
Long-Term Debt $280.3M $248.4M $212.0M
YoY Change 24.53% 17.13% 34.68%
Other Long-Term Liabilities $952.0K $855.0K $66.96M
YoY Change -65.79% -98.72% 192.49%
Total Long-Term Liabilities $478.2M $479.1M $335.9M
YoY Change -0.21% 42.65% 26.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $202.9M $240.9M $112.3M
Total Long-Term Liabilities $478.2M $479.1M $335.9M
Total Liabilities $681.0M $720.0M $448.2M
YoY Change 3.95% 60.66% 21.16%
SHAREHOLDERS EQUITY
Retained Earnings -$760.8M -$715.9M -$526.0M
YoY Change 32.87% 36.11% 111.2%
Common Stock $2.187B $2.167B $2.054B
YoY Change 4.76% 5.46% 14.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.429B $1.455B $1.532B
YoY Change
Total Liabilities & Shareholders Equity $2.110B $2.175B $1.980B
YoY Change -2.94% 9.87% 3.39%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$44.96M -$61.58M -$37.85M
YoY Change -3.64% 62.69% -68.57%
Depreciation, Depletion And Amortization $22.22M $9.448M $7.680M
YoY Change 17.63% 23.02% 93.69%
Cash From Operating Activities $16.80M -$25.36M $5.730M
YoY Change -53.24% -542.58% -140.33%
INVESTING ACTIVITIES
Capital Expenditures $11.41M $9.800M -$15.10M
YoY Change 9.92% -164.92% -37.13%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$5.176M
YoY Change -100.0% -100.0% -73.56%
Cash From Investing Activities -$11.41M -$9.800M -$20.27M
YoY Change -62.33% -51.66% -53.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.84M -1.850M 8.192M
YoY Change 143.53% -122.58% -230.65%
NET CHANGE
Cash From Operating Activities 16.80M -25.36M 5.730M
Cash From Investing Activities -11.41M -9.800M -20.27M
Cash From Financing Activities 30.84M -1.850M 8.192M
Net Change In Cash 36.22M -37.01M -6.350M
YoY Change 98.08% 482.83% -90.09%
FREE CASH FLOW
Cash From Operating Activities $16.80M -$25.36M $5.730M
Capital Expenditures $11.41M $9.800M -$15.10M
Free Cash Flow $5.381M -$35.16M $20.83M
YoY Change -78.93% -268.83% 112.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001845257
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40478
dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2300
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
dei City Area Code
CityAreaCode
602
dei Local Phone Number
LocalPhoneNumber
767-2100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
LFST
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
378607491
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42605000
CY2023Q3 us-gaap Liabilities
Liabilities
720018000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108621000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
149716000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100868000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
71929000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23734000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
264250000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
233223000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
190067000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
194189000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
180685000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
199431000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
233615000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
263294000
CY2023Q3 us-gaap Goodwill
Goodwill
1293426000
CY2022Q4 us-gaap Goodwill
Goodwill
1272939000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13023000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10795000
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1910816000
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1940648000
CY2023Q3 us-gaap Assets
Assets
2175066000
CY2022Q4 us-gaap Assets
Assets
2173871000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10400000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12285000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83618000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
75650000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
91030000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30428000
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8964000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
15876000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43604000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38824000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3258000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2936000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
240874000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
175999000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
248371000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
225079000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
191515000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
212586000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38403000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
38701000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
855000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2783000
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
479144000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
479149000
CY2022Q4 us-gaap Liabilities
Liabilities
655148000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
378607000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
378607000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
375964000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
375964000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
3788000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3761000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2162766000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2084324000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4381000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3274000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-715887000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-572636000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1455048000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1518723000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2175066000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2173871000
CY2023Q3 us-gaap Revenues
Revenues
262895000
CY2022Q3 us-gaap Revenues
Revenues
217560000
us-gaap Revenues
Revenues
775062000
us-gaap Revenues
Revenues
630182000
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
186686000
CY2022Q3 us-gaap Other General Expense
OtherGeneralExpense
157267000
us-gaap Other General Expense
OtherGeneralExpense
556280000
us-gaap Other General Expense
OtherGeneralExpense
455857000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
130945000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
81248000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
317425000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
288176000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19621000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
17884000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
58220000
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
us-gaap Depreciation And Amortization
DepreciationAndAmortization
50311000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
337252000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
256399000
us-gaap Operating Expenses
OperatingExpenses
931925000
us-gaap Operating Expenses
OperatingExpenses
794344000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-74357000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-38839000
us-gaap Operating Income Loss
OperatingIncomeLoss
-156863000
us-gaap Operating Income Loss
OperatingIncomeLoss
-164162000
CY2023Q3 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
1867000
CY2022Q3 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
1176000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
4443000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
562000
CY2023Q3 lfst Transaction Costs
TransactionCosts
0
CY2022Q3 lfst Transaction Costs
TransactionCosts
210000
lfst Transaction Costs
TransactionCosts
89000
lfst Transaction Costs
TransactionCosts
507000
CY2023Q3 us-gaap Interest Expense
InterestExpense
5477000
CY2022Q3 us-gaap Interest Expense
InterestExpense
4189000
us-gaap Interest Expense
InterestExpense
15688000
us-gaap Interest Expense
InterestExpense
14763000
CY2023Q3 us-gaap Other Expenses
OtherExpenses
1000
CY2022Q3 us-gaap Other Expenses
OtherExpenses
144000
us-gaap Other Expenses
OtherExpenses
70000
us-gaap Other Expenses
OtherExpenses
144000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3611000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3367000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11404000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14852000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77968000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42206000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-168267000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-179014000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16385000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4353000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26964000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10106000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61583000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-37853000
us-gaap Net Income Loss
NetIncomeLoss
-141303000
us-gaap Net Income Loss
NetIncomeLoss
-168908000
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.11
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.39
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.39
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.48
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.48
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
372476
us-gaap Depreciation And Amortization
DepreciationAndAmortization
58220000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
372476
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
357520
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
357520
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
365556
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
365556
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
354057
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
354057
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61583000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-37853000
us-gaap Net Income Loss
NetIncomeLoss
-141303000
us-gaap Net Income Loss
NetIncomeLoss
-168908000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
230000
CY2022Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3185000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1107000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3185000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61353000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34668000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140196000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-165723000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1494876000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61583000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
230000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21525000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1455048000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1531301000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-37853000
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-865000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3185000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35735000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1531503000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1518723000
us-gaap Net Income Loss
NetIncomeLoss
-141303000
lfst Adoption Of Asu Two Zero One Six To One Three
AdoptionOfAsuTwoZeroOneSixToOneThree
-1948000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3399000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1107000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81868000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1455048000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1545028000
us-gaap Net Income Loss
NetIncomeLoss
-168908000
lfst Stock Issued During Period Value Restricted Stock Units Releases
StockIssuedDuringPeriodValueRestrictedStockUnitsReleases
-37000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1050000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3185000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
153285000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1531503000
us-gaap Profit Loss
ProfitLoss
-141303000
us-gaap Profit Loss
ProfitLoss
-168908000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
50311000
lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
30225000
lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
0
us-gaap Share Based Compensation
ShareBasedCompensation
78469000
us-gaap Share Based Compensation
ShareBasedCompensation
152235000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3380000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1592000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1351000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
4443000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
562000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5105000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-144000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48484000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
34606000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
52293000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5811000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3848000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1109000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
7622000
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-588000
lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-30109000
lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
65568000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
18816000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33679000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16871000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29106000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
68871000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19820000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
40294000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48926000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-109165000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
25000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
237474000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
188000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7266000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1821000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
181230000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
1609000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
6402000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
12290000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
478000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16589000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34601000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66016000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-57693000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108621000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148029000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42605000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90336000
us-gaap Interest Paid Net
InterestPaidNet
15424000
us-gaap Interest Paid Net
InterestPaidNet
9518000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
416000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1780000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
264000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
1985000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
7719000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
5303000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
8607000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Accounting Estimates</span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q3 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
CY2023Q3 lfst Common Stock Held By Non Affiliates
CommonStockHeldByNonAffiliates
700000000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
262895000
CY2023Q3 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
217560000
CY2022Q3 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
775062000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
630182000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0693
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0647
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
2339000
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
2664000
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
1610000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
254137000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
237072000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64070000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42883000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
190067000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
194189000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9448000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7680000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27698000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20157000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
14270000
us-gaap Operating Lease Cost
OperatingLeaseCost
42842000
us-gaap Variable Lease Cost
VariableLeaseCost
0
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
us-gaap Operating Lease Payments
OperatingLeasePayments
47356000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13844000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9794000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
64442000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
61036000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
53452000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
40192000
CY2023Q3 lfst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
50154000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
279070000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
43951000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
235119000
CY2022Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
14223000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
38297000
CY2023Q3 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
2364000
CY2023Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
1602000
CY2022Q4 us-gaap Goodwill
Goodwill
1272939000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
20733000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-246000
CY2023Q3 us-gaap Goodwill
Goodwill
1293426000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
366729000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
133114000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
233615000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
365886000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
102592000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
263294000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10173000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10204000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30522000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30154000
CY2022Q3 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
3
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
3
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
9
CY2023Q3 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
0
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
173000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
181000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
1024000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
649000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
372000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
1842000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
351000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
138000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
581000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
26000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
221000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
79000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
0
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
368000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
0
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
10000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
22000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
66000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
589000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
843000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
2272000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
6394000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
20733000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
45621000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
8192000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
22878000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
51485000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
806000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
893000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
2491000
CY2022Q3 lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
7386000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
21985000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
48994000
CY2022Q3 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
589000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
843000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
2272000
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
28479000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
4426000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17824000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17430000
lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
1985000
CY2022 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
11221000
lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-6402000
CY2022 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-12515000
lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
-4443000
CY2022 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
1688000
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8964000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17824000
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
8964000
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17824000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
257143000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
233964000
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2595000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2345000
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6177000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6540000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
248371000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
225079000
CY2023Q3 us-gaap Interest Expense
InterestExpense
5477000
CY2022Q3 us-gaap Interest Expense
InterestExpense
4189000
us-gaap Interest Expense
InterestExpense
15688000
us-gaap Interest Expense
InterestExpense
14763000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
649000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2595000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2595000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2595000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
2595000
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
246114000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
257143000
CY2023Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
263473000
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
235049000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.056
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
21525000
CY2022Q3 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
34870000
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
78469000
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
152235000
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
169323
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16385000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4353000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26964000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10106000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.103
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.16
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
3000000
us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
8000000
CY2022Q3 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
50000000
CY2022Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
50000000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-61583000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37853000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-141303000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-168908000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
372476
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
357520
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
365556
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
354057
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.11
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.39
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.39
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.48
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.48
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43200
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
44042
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
lfst-20230930_cal.xml Edgar Link unprocessable
lfst-20230930_def.xml Edgar Link unprocessable
lfst-20230930_lab.xml Edgar Link unprocessable
0000950170-23-061118-index-headers.html Edgar Link pending
0000950170-23-061118-index.html Edgar Link pending
0000950170-23-061118.txt Edgar Link pending
0000950170-23-061118-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lfst-20230930.htm Edgar Link pending
lfst-20230930.xsd Edgar Link pending
lfst-ex31_1.htm Edgar Link pending
lfst-ex31_2.htm Edgar Link pending
lfst-ex32_1.htm Edgar Link pending
lfst-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
lfst-20230930_pre.xml Edgar Link unprocessable
lfst-20230930_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending